Contrast echocardiographic mapping of collateralized myocardium in humans before and after coronary angioplasty

Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland.

Conventional coronary arteriography is able to demonstrate the presence of coronary collateral vessels but cannot delineate the specific region of myocardium to which they supply blood. To test the hypothesis that contrast echocardiography can specifically identify collateralized myocardium, contrast echocardiographic perfusion "maps" were compared in patients with (n = 12) and without (n = 12) angiographic evidence of coronary collateral flow, both before and after coronary angioplasty. Contrast echocardiographic images of the mid-left ventricle in the short-axis view at end-diastole were obtained after separate injections of a sonicated contrast agent into both the right and the left coronary arteries. A computer-based contouring system was used to determine the individual areas of myocardium perfused by each of the two coronary arteries and then to superimpose the images of the two perfusion beds. The resulting area of overlapping perfusion represented myocardium receiving blood flow from both coronary systems and was defined as collateralized myocardium. To normalize for heart size, overlap area was expressed as a percent of total myocardial area, which was the area between endocardium and epicardium in the short-axis view. To adjust for differences in vascular distribution, overlap area was expressed as a percent of the perfusion area of the recipient vessel. In patients with angiographic collateral flow, the recipient vessel was that vessel receiving the collateral flow. In patients without angiographic collateral flow, the right coronary artery was considered the recipient vessel. Overlap area was 1.3 +/- 0.4% of total myocardial area and 6.6 +/- 1.7% of recipient vessel area in patients without angiographic evidence of collateral flow compared with 30.6 +/- 2.5% and 89.2 +/- 6.4%, respectively, in patients with angiographic collateral flow (p less than 0.001 for both). In four patients in whom angiographic collateral flow was abolished by angioplasty, overlap area decreased from 30.3 +/- 5.3% to 6.8 +/- 2.7% of total myocardial area and from 100% to 18.5 +/- 5.4% of recipient vessel area (p less than 0.05 for both). Thus, contrast echocardiography is able to map the specific myocardial territory perfused by coronary collateral flow and document an immediate reduction in perfusion in this territory when collateral flow is abolished by angioplasty.

This article has been cited by other articles:

				R. Vogel, R. Zbinden, A. Indermuhle, S. Windecker, B. Meier, and C. Seiler Collateral-flow measurements in humans by myocardial contrast echocardiography: validation of coronary pressure-derived collateral-flow assessment Eur. Heart J., January 2, 2006; 27(2): 157 - 165. [Abstract] [Full Text] [PDF]

				S. Kaul and H. Ito Microvasculature in Acute Myocardial Ischemia: Part II: Evolving Concepts in Pathophysiology, Diagnosis, and Treatment Circulation, January 27, 2004; 109(3): 310 - 315. [Full Text] [PDF]

				A. Distante, R. Dankowski, P. Mincarone, C.G. Leo, E. Gianicolo, P. Voci, M.A. Morales, and D. Rovai Contrast echocardiography and medical economics: looking into the crystal ball Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C39 - C47. [Abstract] [PDF]

				S F de Marchi, M Schwerzmann, M Fleisch, M Billinger, B Meier, and C Seiler Quantitative contrast echocardiographic assessment of collateral derived myocardial perfusion during elective coronary angioplasty Heart, September 1, 2001; 86(3): 324 - 329. [Abstract] [Full Text] [PDF]

				C. Quintilio, P. Voci, F. Bilotta, G. Luzi, F. Chiarotti, M. C. Acconcia, C. Mercanti, and B. Marino Risk factors of incomplete distribution of cardioplegic solution during coronary artery grafting J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 439 - 447. [Abstract] [Full Text]